Armistice Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $29.4M | Sell |
|
|||||
|
2023
Q3 | $59.4M | Sell |
|
|||||
|
2023
Q2 | $144M | Buy |
|
|||||
|
2023
Q1 | $137M | Buy |
|
|||||
|
2022
Q4 | $158M | Buy |
|
|||||
|
2022
Q3 | $133M | Sell |
|
|||||
|
2022
Q2 | $137K | Buy |
|
|||||
|
2022
Q1 | $112M | Buy |
|
|||||
|
2021
Q4 | $123M | Buy |
|
|||||
|
2021
Q3 | $126M | Buy |
|
|||||
|
2021
Q2 | $107M | Buy |
|
|||||
|
2021
Q1 | $91.8M | Buy |
|
|||||
|
2020
Q4 | $59.7M | Buy |
|
|||||
|
2020
Q3 | $27.9M | Sell |
|
|||||
|
2020
Q2 | $31.1M | Sell |
|
|||||
|
2020
Q1 | $24M | Buy |
|
|||||
|
2019
Q4 | $15.5M | Buy |
|